Class IOngoingVoluntary: Firm initiated
Trafa Pharmaceutical Inc.: food recall H-1144-2026
Trafa Pharmaceutical Inc. of Chicopee, MA recalled Trafa Pharmaceuticals Inc. brand ORGANIC MORINGA LEAF POWDER; NET WEIGHT: 15 KGS; packaged in brown paper bags with a… Reason: Potential contamination with Salmonella. The FDA listed it as Class I in its Enforcement Report dated Jul 15, 2026; distribution: New York.
Record status as published: Ongoing. openFDA data last updated Oct 21, 2026.
Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.
Recall details
- Product
- Trafa Pharmaceuticals Inc. brand ORGANIC MORINGA LEAF POWDER; NET WEIGHT: 15 KGS; packaged in brown paper bags with a white label
- Product quantity
- 500 kg
- Reason for recall
- Potential contamination with Salmonella
- Codes, lots and dates on the package
- BATCH #TRF-2025050801 MAN. DATE: 2025-05-08 RESTEST. DATE: 2028-05-07
- Distribution pattern
- NY
- Recalling firm
- Trafa Pharmaceutical Inc., Chicopee, MA
- Classification
- Class I — the FDA uses this class for a situation in which there is a reasonable probability that using or being exposed to the product will cause serious adverse health consequences or death.
- Voluntary or mandated
- Voluntary: Firm initiated
- How the firm first notified customers
Advertisement
Dates
| Event | Date |
|---|---|
| Recall initiated by the firm | Jun 24, 2026 |
| Classified by the FDA | Jul 7, 2026 |
| Published in the Enforcement Report | Jul 15, 2026 |
Advertisement
OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.
Sources
- U.S. Food and Drug Administration, openFDA food enforcement reports, recall number H-1144-2026 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
- Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.